Effect of liraglutide on vascular inflammation in type-2 diabetes: A randomized, placebo-controlled, double-blind, parallel clinical PET/CT trial.
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LIRAFLAME
- 06 Mar 2018 New source identified and integrated (ClinicalTrials.gov; NCT03449654).
- 06 Feb 2017 New trial record